Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer. - Wikidata - awgldk - TriplyDB

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

http://www.wikidata.org/entity/Q37536906

about

Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.

P2860

Q37645001-583F31B1-0E81-4D88-A739-A03C728507FA

P2860

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

http://www.wikidata.org/entity/Q37536906

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@en

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@nl

type

label

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@en

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@nl

prefLabel

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@en

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.

@nl

P1433

Q37536906-DD7582FB-E9BD-4617-AD75-44A78F8E196A

P1476

Q37536906-0501C98C-8644-487D-A7E0-0F3765B040F2

P2093

Q37536906-021AFD21-46AA-4D55-BB05-0D81D1851736

Q37536906-02942EE7-75A2-479B-BAD4-440EC44BEB95

Q37536906-081B17DE-1984-4741-9357-1A0E3CAC7D7B

Q37536906-1BA8C567-2B49-409D-9C85-23CF8430E41B

Q37536906-21BF401F-2F1D-4555-86DB-E00A33AAE13E

Q37536906-472264BC-BF12-47D7-B5F1-771D95EEEC2B

Q37536906-4F07B158-42B7-4FCC-A96A-369519402EB0

Q37536906-60F53765-5656-4860-B8B0-36AEC3D84493

Q37536906-9E4D7CE5-B03A-43F6-9A5E-06B2A20818D7

Q37536906-B9F8CC89-7CD3-4748-B859-7E21BE13BCA2

P2860

Q37536906-021C11BF-0B29-40C1-8B78-78E232854D05

Q37536906-1BCADF09-DB40-4583-8890-AF4D90C98867

Q37536906-2B430345-EA72-441D-8F66-7C868F546191

Q37536906-3213FE17-4797-44E1-AE1C-EEFEFB1E55E8

Q37536906-38C20C39-5C9D-4A61-8292-4D27F2178CC5

Q37536906-3BFBD911-50C3-400B-BF92-A71DAF63BC01

Q37536906-3C67F5B0-99F3-49BA-B654-3EBF57324D97

Q37536906-3E22A300-5ACA-44F7-BF41-218BC13B09BE

Q37536906-47620085-7ED5-4CF5-BAD2-9EEE3DEDD40B

Q37536906-48AF0474-7252-4588-9C83-70FB1D796D7F

P304

Q37536906-AEC89EE8-58CB-4CD0-B540-10FF9B6C89C3

P31

Q37536906-DD49189E-799A-4058-833B-934CE89B3DB0

P356

Q37536906-FC3B0C49-9DEF-4826-AEF0-418E4230EC3E

P407

Q37536906-59F0285C-18C4-4299-93A3-D1BF982D9962

P433

Q37536906-C55BA915-2ABD-4581-B20C-A4F851A6CC78

P478

Q37536906-03D31914-B5BC-4970-A1D8-282F0D17A3E5

P50

Q37536906-5EC966AE-FBF5-4638-88FE-DD3EE1E47853

P577

Q37536906-3D3EDA40-4024-4F65-8E9B-2386D46A3F07

P698

Q37536906-B815E661-D759-4622-950F-B58D956F8100

P932

Q37536906-F8F6446E-875C-42D2-96A4-30DCF18E3D4E

P356

ONCOTARGET.9763

P1433

P1476

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer

@en

P2093

Ana Batista

http://www.w3.org/2001/XMLSchema#string

Hongying Zhao

http://www.w3.org/2001/XMLSchema#string

Igor Garkavtsev

http://www.w3.org/2001/XMLSchema#string

Jingtao Bi

http://www.w3.org/2001/XMLSchema#string

Sheng Zhou

http://www.w3.org/2001/XMLSchema#string

Shiwei Han

http://www.w3.org/2001/XMLSchema#string

Tingting Wang

http://www.w3.org/2001/XMLSchema#string

Xiaona Zhou

http://www.w3.org/2001/XMLSchema#string

Xuemei Ma

http://www.w3.org/2001/XMLSchema#string

Yanxia Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution

Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators

MAP kinase signalling pathways in cancer

Risk of tumorigenesis in overgrowth syndromes: A comprehensive review

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

P304

44406-44416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9763

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27259271

http://www.w3.org/2001/XMLSchema#string

P932

5190106

http://www.w3.org/2001/XMLSchema#string